http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107261134-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107261134-B
titleOfInvention Immunopotentiator for porcine atrophic rhinitis inactivated vaccine and preparation method thereof
abstract The invention discloses an immunopotentiator for an inactivated vaccine of atrophic rhinitis of pigs, which comprises liquid containing dry powder immune particles and a solvent, wherein the liquid containing the dry powder immune particles mainly comprises aluminum hydroxide aqueous solution, ginsenoside, cholesterol, vitamin C, diethylaminoethyl glucan, potassium iodide and polyethylene glycol which are compatible according to a proper proportion. Compared with the prior art, the immunopotentiator for the swine atrophic rhinitis inactivated vaccine prepared by the invention can effectively inhibit the establishment and reactivation of latent infection of Bordetella bronchiseptica and Pasteurella multocida, can shorten the window period of antibody production, improves the immune effect of the swine atrophic rhinitis vaccine, prolongs the immune duration, effectively avoids the latent infection of the swine atrophic rhinitis, provides guarantee for the prevention and eradication of the swine atrophic rhinitis, can be widely applied to a pig farm to prevent and treat the swine atrophic rhinitis, and improves the economic benefit of the pig farm.
priorityDate 2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411660655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453694953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11802

Total number of triples: 37.